Adorial

High Wycombe, United Kingdom Founded: 2014 • Age: 12 yrs Acquired By C4X Discovery
Proprietary in silico genomics platform is utilized for drug discovery.

About Adorial

Adorial is a company based in High Wycombe (United Kingdom) founded in 2014 was acquired by C4X Discovery in March 2016.. Adorial operates in a competitive market with competitors including Helix, Benchling, NantHealth, Genuity Science and Inpharmatica, among others.

  • Headquarter High Wycombe, United Kingdom
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Adorial Ltd
  • Date of Incorporation 15 Dec, 2014
  • Jurisdiction MANCHESTER, ENGLAND
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
    $-1.27 K (USD)
    88
    as on Jul 31, 2017
  • EBITDA
    $-1.27 K (USD)
    88
    as on Jul 31, 2017
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    C4X Discovery

    (Mar 01, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Adorial

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Adorial

Adorial has secured backing from 1 investor. Prominent investors backing the company include C4X Discovery. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Developer of optimized drug discovery and design services
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Adorial

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Adorial

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Adorial Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Adorial

Adorial operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, NantHealth, Genuity Science and Inpharmatica, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Genomic database for clinical research is provided.
domain founded_year HQ Location
Cloud-based bioinformatics platform is offered for biotech research.
domain founded_year HQ Location
Bioinformatics platforms are provided for cancer treatment identification.
domain founded_year HQ Location
AI-based omics data analysis solutions are provided to researchers.
domain founded_year HQ Location
Developer of predictive informatics based platform for drug discovery
domain founded_year HQ Location
Bioinformatics platform is provided for biomarkers and drug discovery.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Adorial

Frequently Asked Questions about Adorial

When was Adorial founded?

Adorial was founded in 2014.

Where is Adorial located?

Adorial is headquartered in High Wycombe, United Kingdom. It is registered at High Wycombe, Buckinghamshire, United Kingdom.

What does Adorial do?

Adorial is a virtual drug discovery company using a proprietary in silico genomics platform to identify novel drug targets. Adorial was spun-out from PGXIS in 2015. Offers a technology platform, Taxonomy3 for the analysis of genetic dataset and will allow broad screening for gene-gene interactions. Adorial identified 18 novel drug targets causally related to Rheumatoid Arthritis RA) using Taxonomy3. These have not been identified in any previous published genetic analysis of RA,.

Who are the top competitors of Adorial?

Adorial's top competitors include Helix, NantHealth and Benchling.

Who are Adorial's investors?

Adorial has 1 investor. Key investors include C4X Discovery.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available